Singapore markets open in 3 hours 4 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
261.84+7.67 (+3.02%)
At close: 04:00PM EDT
262.50 +0.66 (+0.25%)
After hours: 05:38PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 63.10B
Enterprise value 55.73B
Trailing P/E 26.03
Forward P/E 17.15
PEG Ratio (5 yr expected) 0.36
Price/sales (ttm)8.04
Price/book (mrq)5.79
Enterprise value/revenue 7.01
Enterprise value/EBITDA 18.23

Trading information

Stock price history

Beta (5Y monthly) 0.61
52-week change 318.41%
S&P500 52-week change 3-2.90%
52-week high 3292.75
52-week low 3176.36
50-day moving average 3260.36
200-day moving average 3218.84

Share statistics

Avg vol (3-month) 31.65M
Avg vol (10-day) 31.8M
Shares outstanding 5255.76M
Implied shares outstanding 6N/A
Float 8253.94M
% held by insiders 10.27%
% held by institutions 194.48%
Shares short (28 Apr 2022) 43.41M
Short ratio (28 Apr 2022) 41.98
Short % of float (28 Apr 2022) 41.34%
Short % of shares outstanding (28 Apr 2022) 41.33%
Shares short (prior month 30 Mar 2022) 44.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 323 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 30.92%
Operating margin (ttm)36.69%

Management effectiveness

Return on assets (ttm)13.79%
Return on equity (ttm)24.93%

Income statement

Revenue (ttm)7.57B
Revenue per share (ttm)29.39
Quarterly revenue growth (yoy)27.30%
Gross profit (ttm)3.62B
EBITDA 2.9B
Net income avi to common (ttm)2.34B
Diluted EPS (ttm)9.01
Quarterly earnings growth (yoy)27.50%

Balance sheet

Total cash (mrq)7.52B
Total cash per share (mrq)29.56
Total debt (mrq)967.4M
Total debt/equity (mrq)9.58
Current ratio (mrq)4.46
Book value per share (mrq)39.69

Cash flow statement

Operating cash flow (ttm)2.64B
Levered free cash flow (ttm)1.71B